NWF Advisory Services’s Pfizer PFE Stock Holding History

NWF Advisory Services’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.11M	Buy	38,963 +26	+0.1%	+$692	0.1%	139
2026 Q2	$938K	Buy	38,937 +3,212	+9%	+$84K	0.09%	152
2026 Q1	$1M	Sell	35,725 -983	-3%	-$26.2K	0.11%	131
2025 Q4	$914K	Buy	36,708 +3,124	+9%	+$78.8K	0.1%	137
2025 Q3	$856K	Sell	33,584 -4,072	-11%	-$101K	0.09%	150
2025 Q2	$913K	Buy	37,656 +1,162	+3%	+$27.1K	0.11%	137
2025 Q1	$925K	Sell	36,494 -5,994	-14%	-$157K	0.13%	113
2024 Q4	$1.13M	Sell	42,488 -75	-0.2%	-$2.03K	0.17%	81
2024 Q3	$1.23M	Sell	42,563 -3,775	-8%	-$110K	0.18%	95
2024 Q2	$1.3M	Sell	46,338 -227	-0.5%	-$6.25K	0.21%	81
2024 Q1	$1.29M	Buy	46,565 +5,792	+14%	+$161K	0.22%	85
2023 Q4	$1.17M	Buy	40,773 +2,615	+7%	+$79.1K	0.23%	81
2023 Q3	$1.27M	Sell	38,158 -297	-0.8%	-$10.5K	0.3%	67
2023 Q2	$1.41M	Hold	38,455	–	–	0.33%	60
2023 Q1	$1.41M	Buy	+38,455	New	+$1.66M	0.33%	60

Other funds holding PFE

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

Willis Investment Counsel Gainesville, Georgia $1.97B AUM 25.29% 1-Year Est. Return

IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return

Kepler Cheuvreux Nyon $1.65B AUM 36.86% 1-Year Est. Return

NWF Advisory Services's PFE Position: Q3 2026 in Review

NWF Advisory Services increased its Pfizer (PFE) stake by 0.07% in Q3 2026, buying an estimated $692 and bringing the position to 38,963 shares worth $1.11M. The position accounts for 0.1% of the portfolio, ranked #139.

NWF Advisory Services first reported a position in PFE in Q1 2023 and has held it in 15 quarters since. The position peaked at $1.41M in Q2 2023. 603 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

NWF Advisory Services held 38,963 shares of Pfizer worth $1.11M as of Q3 2026.
NWF Advisory Services bought 26 Pfizer shares in Q3 2026, an estimated $692.
Pfizer made up 0.1% of NWF Advisory Services's portfolio in Q3 2026, its #139 holding.
NWF Advisory Services first reported a position in Pfizer in Q1 2023 and has held it in 15 quarters since.
NWF Advisory Services's Pfizer position peaked at $1.41M in Q2 2023.
603 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on NWF Advisory Services's 13F filing for Q3 2026, filed 19 Oct 2026.